First Time Loading...
S

Shandong Pharmaceutical Glass Co Ltd
SSE:600529

Watchlist Manager
Shandong Pharmaceutical Glass Co Ltd
SSE:600529
Watchlist
Price: 28.8 CNY 1.02% Market Closed
Updated: Apr 29, 2024

Shandong Pharmaceutical Glass Co Ltd
Net Income (Common)

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Shandong Pharmaceutical Glass Co Ltd
Net Income (Common) Peer Comparison

Comparables:
1066
603658
300888
300832
300595

Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors

Company Net Income (Common) CAGR 3Y CAGR 5Y CAGR 10Y
S
Shandong Pharmaceutical Glass Co Ltd
SSE:600529
Net Income (Common)
¥737.7m
CAGR 3-Years
12%
CAGR 5-Years
18%
CAGR 10-Years
19%
Shandong Weigao Group Medical Polymer Co Ltd
HKEX:1066
Net Income (Common)
¥2B
CAGR 3-Years
-1%
CAGR 5-Years
6%
CAGR 10-Years
N/A
Autobio Diagnostics Co Ltd
SSE:603658
Net Income (Common)
¥1.2B
CAGR 3-Years
16%
CAGR 5-Years
17%
CAGR 10-Years
N/A
Winner Medical Co Ltd
SZSE:300888
Net Income (Common)
¥1.7B
CAGR 3-Years
45%
CAGR 5-Years
31%
CAGR 10-Years
N/A
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
Net Income (Common)
¥1.7B
CAGR 3-Years
21%
CAGR 5-Years
19%
CAGR 10-Years
N/A
Autek China Inc
SZSE:300595
Net Income (Common)
¥666.6m
CAGR 3-Years
15%
CAGR 5-Years
25%
CAGR 10-Years
N/A

See Also

What is Shandong Pharmaceutical Glass Co Ltd's Net Income (Common)?
Net Income (Common)
737.7m CNY

Based on the financial report for Sep 30, 2023, Shandong Pharmaceutical Glass Co Ltd's Net Income (Common) amounts to 737.7m CNY.

What is Shandong Pharmaceutical Glass Co Ltd's Net Income (Common) growth rate?
Net Income (Common) CAGR 10Y
19%

Over the last year, the Net Income (Common) growth was 20%. The average annual Net Income (Common) growth rates for Shandong Pharmaceutical Glass Co Ltd have been 12% over the past three years , 18% over the past five years , and 19% over the past ten years .